CVS, Aetna Pop On Merger Update

CVS, Aetna Pop On Merger Update

Research  these Stocks on Kapitall’s Playground Now

research now

by: Elizabeth Balboa, Benzinga Staff Writer


CVS Health Corp CVS 3.83% is nearing a deal to buy Aetna Inc AET 1.32% for between $200 and $205 per share, according to Dow Jones sources.

CVS traded up 3.7 percent and Aetna 1.4 percent on the news, while Rite Aid Corporation RAD 6.71% fell 6.7 percent in sympathy and health insurers popped as much as 2.5 percent.


Why It's Important

The market’s positivity echoes that of health analysts deeming the merger a sensible survival strategy for firms in the age of, Inc. AMZN 0.89%.

“We see this potential deal as both evolutionary and revolutionary given the dynamic healthcare environment and push toward consumerism coupled with a challenged retail backdrop and the need to combat a looming AMZN threat,” Citigroup wrote in October.

Mizuho added that the union could set a precedent for the “next generation of formulary management in healthcare services.”

Some analysts have been less enthused, though, with Cantor Fitzgerald downgrading Aetna on the takeover risks.

What's Next

CVS and Aetna have seen their stocks rise a respective 10.6 percent and 13.6 percent since rumors of the $66 million merger first emerged late October. Reuters reported the deal could close as early as December.

Aetna declined to comment on Thursday’s update.



Image Credit: hattiesburgmemory (CVS Pharmacy Uploaded by AlbertHerring) [CC BY 2.0], via Wikimedia Commons

© 2017 Benzinga does not provide investment advice. All rights reserved.


3 responses to “CVS, Aetna Pop On Merger Update”

  1. New Year eve every one of them wish each other

  2. star health says:

    Happy new year to all of you.

  3. styledress says:

    Happy new year to all of you.

Leave a Reply

Your email address will not be published. Required fields are marked *

  • See Most Recent Articles